Insider Transactions in Q2 2021 at X4 Pharmaceuticals, Inc (XFOR)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,641
-1.96%
|
$15,846
$6.64 P/Share
|
|
Jun 24
2021
|
Derek M Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,166
-4.89%
|
$29,162
$7.0 P/Share
|
|
Jun 24
2021
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,417
-3.87%
|
$37,919
$7.01 P/Share
|
|
Jun 23
2021
|
Paula Ragan President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,826
+8.29%
|
-
|
|
Jun 23
2021
|
Derek M Meisner Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+12.79%
|
-
|
|
Jun 23
2021
|
Adam S. Mostafa Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,250
+10.41%
|
-
|
|
Jun 15
2021
|
Paula Ragan President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,826
+9.04%
|
-
|
|
Jun 15
2021
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,417
-4.2%
|
$37,919
$7.84 P/Share
|
|
Jun 15
2021
|
Adam S. Mostafa Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,250
+11.19%
|
-
|
|
Jun 15
2021
|
Derek M Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,166
-5.42%
|
$29,162
$7.84 P/Share
|
|
Jun 15
2021
|
Derek M Meisner Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+13.98%
|
-
|
|
Jun 02
2021
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
2,400
-0.59%
|
$21,600
$9.5 P/Share
|
|
Jun 01
2021
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
4,104
-0.99%
|
$36,936
$9.41 P/Share
|
|
May 03
2021
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
2,400
-0.58%
|
$19,200
$8.33 P/Share
|
|
Apr 05
2021
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
2,400
-0.57%
|
$21,600
$9.17 P/Share
|